Biotechne share price
WebApr 11, 2024 · Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. … WebApr 10, 2024 · A high-level overview of Bio-Techne Corporation (TECH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …
Biotechne share price
Did you know?
WebNov 25, 2024 · ViacomCBS Inc.'s (NASDAQ:VIAC) Intrinsic Value Is Potentially 90% Above Its Share Price Feb 3, 2024 Digital Turbine, Inc. (NASDAQ:APPS) Stocks Pounded By … Web18 hours ago · About Price to Free Cash Flow. The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a …
WebBio-Techne Corporation's (NASDAQ:TECH) recent US$602m market cap decline means a loss of US$6.2k for insiders who bought this year. Simply Wall St. Aug-30-22 07:00AM. BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE. WebFind the latest Bio-Techne Corporation (TECH) stock quote, history, news and other vital information to help you with your stock trading and investing. Discover historical prices for TECH stock on Yahoo Finance. View daily, weekly or … Find the latest Bio-Techne Corporation (TECH) stock discussion in Yahoo … Interactive Chart for Bio-Techne Corporation (TECH), analyze all the … See Bio-Techne Corporation (TECH) stock analyst estimates, including earnings … Find out all the key statistics for Bio-Techne Corporation (TECH), including valuation … See the company profile for Bio-Techne Corporation (TECH) including business … Get the detailed quarterly/annual income statement for Bio-Techne Corporation … Find out the direct holders, institutional holders and mutual fund holders for Bio … See Bio-Techne Corporation (TECH) Environment, Social and Governance … Find the latest Bio-Techne Corporation (TECH) stock quote, history, news and …
WebApr 5, 2024 · Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus. Feb. 3, 2024 at 6:53 a.m. ET by Tomi Kilgore. WebBased in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for ...
WebApr 6, 2024 · Get Bio-Techne Corp (TECH:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
WebAug 5, 2024 · Delivered adjusted earnings per share (EPS) of $1.87 versus $1.00 one year ago. Full year GAAP EPS was $3.47 vs $5.82 one year ago. Full year adjusted EPS was $6.75 vs $4.55 in the prior year. ... the impact of the growing number of producers of biotechnology research products and related price competition, general economic … ear nose and throat doctors queen creek azWebApr 11, 2024 · The stock has a market capitalization of $11.83 billion, a price-to-earnings ratio of 46.70, a price-to-earnings-growth ratio of 2.40 and a beta of 1.25. ... analysts … ear nose and throat doctors port orange flWebDec 3, 2024 · This left a book value of Bio-Techne of $1.343 billion, or a per share value of $34.16 vs. $39.98, or almost a $6 per share difference. Please keep in mind this is not what I am suggesting the ... ear nose and throat doctors poulsbo waWebMay 2, 2024. EPS forecast (this quarter) $0.53. Annual revenue (last year) $1.1B. Annual profit (last year) $271.9M. Net profit margin. 24.60%. csx runaway trainWebConsensus Price Target is the stock price analysts expect to see within a period of 0-18 months. EPS and Revenue estimates are for the next 12 months. Markets data provided … ear nose and throat doctors phoenixWebThe average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. ... Whether you're buying your first share or investing for the long-haul, we have you covered ... ear nose and throat doctor south bend indianaWebThe Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Bio-Techne Corp’s P/E ratio is 45.86. csx rushville indiana